Pulmonary Drug Delivery Systems Market Trends, Competitive Landscape, Key Developments, Product Type, Application, Region

                                                  Pulmonary Drug Delivery Systems Market

Pulmonary administration is an efficient treatment strategy for lung and other disorders. The Pulmonary Drug Delivery Systems Market can deliver drugs straight to the lungs (PDDS). Maintaining local drug concentration, reducing adverse effects, controlling drug release, promoting drug absorption, extending drug action time, and improving patient compliance are all advantages of PDDS. Polymers have been widely used to create innovative PDDS. Chitosan (CS) is a natural cationic polysaccharide that is abundant in its source. It possesses several unique physicochemical features, as well as strong biocompatibility and biodegradability. For decades, CS has been a prominent biomaterial in pharmaceutics and is widely employed in medication delivery.

Many amino groups can be found in CS. The positive charges present can interact significantly with the negatively charged mucosa membranes, resulting in CS adsorption on the mucosal surface is facilitated, cilia clearance is avoided, and adhesion and penetration rates on the cell membrane are improved. Furthermore, investigations have demonstrated that CS can open cell tight junctions, promoting drug transport through epithelial tissue. As a result, CS is an excellent material for PDDS. This chapter will concentrate on the research advancements and applications of CS in PDDS. Many representative and advanced studies on CS-based PDDS are thoroughly discussed.

The global pulmonary drug delivery systems market is estimated to account for US$ 30,005.80 MN in terms of value in 2020 and is expected to reach US$ 41,072.7 by the end of 2027.

The rising awareness of pulmonary disorders, as well as the availability of numerous pulmonary drug delivery devices, are driving market expansion. The widespread availability of pulmonary drug delivery systems in retail pharmacies and e-pharmacies is likely to boost the industry. Furthermore, increased R&D activities have fostered the development of innovative drug delivery systems, and new product releases by market players are poised to have a substantial impact on global demand for pulmonary drug delivery systems. For example, in October 2018, Philips released the InnoSpire Go, a drinkable mesh nebulizer. It is a portable, hand-held, small-sized, light-weight nebulizer that can dispense medications in a matter of minutes. As a result, the existence of Top manufacturers and their new product offerings are helping to drive market expansion.

During the forecast period, the Pulmonary Drug Delivery Systems Market is expected to grow at a CAGR of 4%. This is due to technological developments, an increase in the incidence of respiratory disorders, and a desire for pulmonary medication delivery as an alternative route of drug delivery. Due to various advantages connected with this delivery system, such as the large surface area present in alveolar sacs, high drug loading efficiency, and high vascularization, pulmonary drug delivery systems are optimal drug approaches when compared to conventional drug delivery approaches. Furthermore, the rising prevalence of chronic respiratory disorders will increase the demand for a pulmonary drug delivery system. The large rise in the targeted patient pool from the previous year will raise demand for pulmonary medication delivery systems. Furthermore, technological advancements in the pulmonary medication delivery system, in conjunction with government and non-government initiatives, will generate attractive prospects for the industry in the coming years.

Segmentations

o     Product Type  Nebulizers MDIs DPIs

o    Application; Asthma  COPD Cystic Fibrosis

o     Region North America  Latin America  Europe  Asia Pacific  Middle East Africa

 Competitive Landscape- 3M Health Care, Allied Healthcare Products, Inc., AstraZeneca plc, Boehringer Ingelheim, CareFusion Corporation, GF Health Products, Inc., GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, Omron Healthcare, Inc., Glenmark Pharmaceuticals, PARI Respiratory Equipment, Inc., and Philips Healthcare.

Comments

Post a Comment

Popular posts from this blog

Bamboos Market Size, Share, Trends, Outlook, and Opportunity Analysis, 2022-2028

Image
                                                                                       Bamboos The global bamboos market was worth USD 53.28 billion in 2020, and it is predicted to increase at a compound annual growth rate (CAGR) of 5.7% between 2021 and 2028. Growing infrastructure development investments, increased usage of sustainable building construction resources, and rising consumer knowledge about the uses and benefits of Bamboos are likely to boost the over the forecast period. Bamboo and rattan have numerous environmental, economic, and social advantages. Bamboo is a renewable resource that can grow in a variety of climates, but thrives in tropical climates. When compared to trees, it produces around 35% more oxygen and absorbs 40% more carbon dioxide, resulti...
Read more

Banana Puree Market Future Size and Research, Key Manufacturer and CAGR Status

Image
Banana Puree Market Bananas are blended into a soft, thick pulp to create banana puree. Bananas can be processed using a blender, a potato masher, or by pressing them through a sieve. The consumption of banana puree lowers the risk of heart disease, maintains blood pressure and acidity levels, and balances body water. Banana puree is also a good source of potassium and dietary fiber. A functional beverage typically aims to provide consumers with certain health advantages. The majority of functional drinks include pureed fruits, vegetables, and vitamins. Energy drinks, performance drinks, and improved fruit drinks are a few examples of functional drinks. Greater consumer awareness coupled with a high disposable income ensures that developed regions such as North America remain the largest markets for functional beverages for some time to come. Functional beverages may contain a significant amount of banana puree, which is advantageous for the global banana puree industry. In the bever...
Read more

The Automated Liquid Handling System Is A Multipurpose Lab Tool Designed To Sample, Mix, And Combine Liquid Samples Automatically.

Image
  Automated Liquid Handling Systems Automated liquid handling systems are multifunctional instruments created to carry out a variety of tasks in laboratories, including automatically collecting, combining, and mixing liquid samples. By performing a number of laboratory tasks, the automated liquid handling system facilitates the removal of sample contamination and decreases the manual work of lab personnel. These workstations have the capacity to measure samples, add reagents, and guarantee the consistent addition of liquids to bioassays. The volume of samples that can be handled varies between liquid handling workstations, and they are available with a variety of integrated software to preserve the footprint of the operations completed by these instruments. The volume of the fluid or liquid is the typical problem with the conventional liquid handling system. As a result, automated liquid handling systems are being widely used in laboratories to reduce processing time and eliminate...
Read more